Facing de-listing, Dublin-based public company headed for reverse stock split
March 13, 2019 at 14:24 PM EDT
Navidea is trying to focus on winning regulatory approval for a drug to diagnose rheumatoid arthritis early, but first has to keep its stock listed on a major exchange.